Cincinnati, OH - The American Heart Association (AHA) is recommending ambulatory blood pressure monitoring (ABPM) for certain children and adolescents suspected of having high blood pressure. In a ...
NEW YORK CITY, NY — New data from the SYMPLICITY HTN-3 trial show that catheter-based denervation of the renal artery in resistant-hypertension patients had no impact on 24-hour ambulatory blood ...
Readings obtained with ambulatory blood pressure monitoring (ABPM) are more strongly associated with risks of all-cause and cardiovascular mortality than are measurements taken in the clinic, a large ...
Get unlimited access to ad-free articles and exclusive content. NicOx S.A. (Eurolist: COX) today announced that clinical results of an exploratory pharmacodynamic study for naproxcinod using ...
PETAH TIKVA, Israel & BOCA RATON, Fla., December 30, 2025--(BUSINESS WIRE)--Biobeat Technologies, Ltd., developer of the first FDA-cleared, 24-hour ambulatory blood pressure monitoring (ABPM) system ...
The once-weekly injectable tirzepatide (Mounjaro, Zepbound) was associated with reduced blood pressure (BP) in a prospective substudy of the SURMOUNT-1 trial. Depending on the dose of the combination ...
Please provide your email address to receive an email when new articles are posted on . Patients with osteoarthritis or rheumatoid arthritis and elevated risk for CVD who were treated with ibuprofen ...
PETAH TIKVA, Israel, May 26, 2021 /PRNewswire/ -- Biobeat, a global leader in wearable remote patient monitoring solutions for the healthcare continuum, announced today the launch of its new wearable ...
Ambulatory blood pressure monitoring (ABPM) is an accurate method for evaluating hypertension, yet its use in clinical practice may be limited by availability, cost and patient inconvenience. The ...
Patients find ambulatory blood pressure monitoring (ABPM) less acceptable than home self-monitoring, research has revealed. Overall, around one in four patients found ABPM problematic, with home ...
Biobeat Secures $50 Million Series B Financing to Advance Commercialization of its Patch-worn, Cuff-less 24-hour Ambulatory Blood Pressure Monitor Biobeat Technologies, Ltd., developer of the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results